The World Health Organisation has lit a fire under Whitehall. Three Ebola vaccines are in development, and the WHO is whispering the P-word. Pandemic.
Not just an outbreak. A global spread. Britain is now fast-tracking clinical trials.
The move is a direct response to intelligence from Geneva. The new strain, detected in equatorial Africa, shows higher transmissibility. Fatality rates remain brutal.
Around 50 per cent. The usual suspects are behind the vaccines. Big pharma.
Oxford. Imperial. But the politics here is delicate.
No one wants to be accused of profiteering. Or panic. The Health Secretary is already facing questions about preparedness.
The opposition smells blood. The backbenches are restless. They remember the last pandemic.
The contracts. The cronyism. The public inquiry is still ongoing.
This time, ministers are trying a different tack. Transparency. Speed.
But the clock is ticking. The first UK clinical trial is set for three weeks. Volunteers are being recruited.
The military is on standby for logistics. The mood in Whitehall is tense. Briefings are being held behind closed doors.
The key players are the Chief Medical Officer and the Vaccine Taskforce. They are working on a ‘war footing’ as one insider put it. The main concern is manufacturing capacity.
Can we produce enough doses? And what about distribution? The WHO is calling for global coordination.
But national interest comes first. Expect a flurry of announcements this week. The Treasury is signing off on emergency funds.
The messaging is critical. No lockdowns this time. Or so they say.
The science is uncertain. The media is already circling. Headlines will be stark.
But the real game is inside the room. Who gets the contract. Who gets the credit.
And who takes the blame if it goes wrong.
